Exercise or conversion by William Shakespeare of 251084 shares of Theseus Pharmaceuticals subject to Rule 16b-3

THRXDelisted Stock  USD 3.71  0.14  3.92%   
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Theseus Pharmaceuticals I officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Theseus insider trading alert for exercise of common stock by William Shakespeare, President of Research and Development, on 7th of November 2023. This event was filed by Theseus Pharmaceuticals I with SEC on 2023-11-07. Statement of changes in beneficial ownership - SEC Form 4

Theseus Pharmaceuticals Fundamental Analysis

We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Theseus Pharmaceuticals is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Theseus Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Theseus Pharmaceuticals Related Equities

TERNTerns Pharmaceuticals   5.17   
0%
69.0%
DSGNDesign Therapeutics   1.69   
0%
22.0%
IMRXImmuneering Corp   1.40   
0%
18.0%
BPMCBlueprint Medicines   0.87   
0%
11.0%
PMVPPmv Pharmaceuticals   0.63   
0%
8.0%
XFORX4 Pharmaceuticals   0.45   
0%
6.0%
RCUSArcus Biosciences   0.29   
3.0%
0%
ERASErasca   0.67   
8.0%
0%
CGEMCullinan Oncology   1.18   
15.0%
0%
DAWNDay One   1.86   
24.0%
0%
ELVNEnliven Therapeutics   2.58   
34.0%
0%
MRSNMersana Therapeutics   2.75   
36.0%
0%
IPSCCentury Therapeutics   4.08   
54.0%
0%
HOOKHookipa Pharma   5.12   
68.0%
0%
RLAYRelay Therapeutics   5.74   
77.0%
0%
GLUEMonte Rosa   7.45   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in Theseus Stock

If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing